Eylea 2 MG/0.05 ML vial 0.05ML
Ended Awarded
- Contract number
- SPE2DB25FQAHZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,514
Award facts
- Contract value 100% obligated
- $2,513.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,513.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Eylea 2 mg/0.05 ml vials. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a specialized pharmaceutical procurement under DLA's broader pharmaceutical supply mission. This award carries no set-aside designation, indicating that DMS Pharmaceutical Group competed on an open basis while leveraging its small business status.
This delivery order is issued under DMS Pharmaceutical Group's significant single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's positioning as a critical supplier in the federal pharmaceutical supply chain reflects its consistent track record of providing specialized pharmaceutical products, including specialty medications and injections, directly to military health system distribution centers.
Quick answers
Who was awarded contract SPE2DB25FQAHZ?
SPE2DB25FQAHZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FQAHZ worth?
The government has obligated $2,514 on SPE2DB25FQAHZ.
Is contract SPE2DB25FQAHZ an order under another contract?
Yes. SPE2DB25FQAHZ is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB25FQAHZ competed?
The extent of competition for SPE2DB25FQAHZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award